COVIran Barekat
COVID-19 vaccine developed by Iranian state-owned Shifa Pharmed Industrial Group
COVIran Barekat[1] is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, part of the Barkat Pharmaceutical Group.[2][3][4] It is an inactivated virus-based vaccine.[1] Iranian authorities authorized its emergency use. It is the first locally developed COVID-19 vaccine to be approved for emergency use in the Middle East.[5]
 A vial of COVIran Barakat | |
| Vaccine description | |
|---|---|
| Target disease | SARS-CoV-2 |
| Type | Killed/Inactivated |
| Clinical data | |
| Synonyms | COVIRAN کووایران برکت |
| Routes of administration | Intramuscular |
| ATC code |
|
| Legal status | |
| Legal status |
|
References change
- ↑ 1.0 1.1 Mallapaty S (August 2021). "Iran hopes to defeat COVID with home-grown crop of vaccines". Nature. 596 (7873): 475. Bibcode:2021Natur.596..475M. doi:10.1038/d41586-021-02216-z. PMID 34404947. S2CID 237198729.
- ↑ Motamedi M (29 December 2020). "COVIran Barakat: Iran launches human trials of its COVID vaccine". Al Jazeera. Archived from the original on 31 January 2021.
- ↑ "Iran's leader gets locally made coronavirus vaccine shot". Reuters. 2021-06-25. Retrieved 2021-08-24.
- ↑ "About - شرکت گروه صنایع شفافارمد". 2021-04-15. Retrieved 2021-09-03.
- ↑ Baghishov E (14 June 2021). "Iran issues license on its coronavirus vaccine". Trend.Az. Archived from the original on 2021-06-14. Retrieved 14 June 2021.
